⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1005162 | 0.79 | — | — | |
| SCHEMBL2264803 | 0.78 | — | — | |
| SCHEMBL2264806 | 0.78 | — | — | |
| SCHEMBL10760377 | 0.75 | — | — | |
| SCHEMBL402652 | 0.75 | — | — | |
| SCHEMBL3945530 | 0.73 | MAPT (0.42) | — | |
| SCHEMBL8739098 | 0.67 | KDM1A (0.40) | — | |
| SCHEMBL30147954 | 0.66 | — | — | |
| SCHEMBL1156109 | 0.66 | — | — | |
| SCHEMBL260538 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3642264-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | Momentive Performance Materials Inc. (US) | 2020-04-29 | — | — | EP | claimed |
| US-10385210-B2 | Curable silicone composition and applications and uses thereof | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2019-08-20 | — | — | US | claimed |
| US-10287400-B2 | Curable silicone composition and applications and uses thereof | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2019-05-14 | — | — | US | claimed |
| EP-3443027-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | Momentive Performance Materials Inc. (US) | 2019-02-20 | — | — | EP | claimed |
| WO-2018236679-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2018-12-27 | — | — | WO | claimed |
| US-20180362764-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2018-12-20 | — | — | US | claimed |
| US-20170298188-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-10-19 | — | — | US | claimed |
| WO-2017180329-A1 | CURABLE SILICONE COMPOSITION AND APPLICATIONS AND USES THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2017-10-19 | — | — | WO | claimed |
| EP-1741419-B1 | Dental material with unusual fluorine distribution | IVOCLAR VIVADENT AG (LI) | 2009-02-25 | — | — | EP | claimed |
| EP-0581132-A2 | Substituted Bicyclo[3.1.0]hexanes and their use as herbicide | BAYER AG (DE) | 1994-02-02 | — | — | EP | claimed |
| CN-114874209-B | Oxadiazole transient receptor potential channel inhibitors | 豪夫迈·罗氏有限公司 | 2024-08-06 | — | — | CN | disclosed |
| WO-2024150099-A1 | ELECTRONIC DEVICE AND METHOD FOR OPERATING SAME | 株式会社半導体エネルギー研究所 | 2024-07-18 | — | — | WO | disclosed |
| WO-2023234427-A1 | ANTIBODY-MULTIDRUG CONJUGATE PRECURSOR AND SYNTHETIC INTERMEDIATE THEREOF | ＵＢＥ株式会社 | 2023-12-07 | — | — | WO | disclosed |
| WO-2023234426-A1 | ANTIBODY-MULTIDRUG CONJUGATE | ＵＢＥ株式会社 | 2023-12-07 | — | — | WO | disclosed |
| CN-116829571-A | Novel spiral pyrrolidine derived antiviral drugs | 英安塔制药有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2006040056-A1 | HETEROCYCLIC SUBSTITUTED BISARYLUREA DERIVATIVES AS KINASE INHIBITORS | MERCK PATENT GMBH (DE) | 2006-04-20 | — | — | WO | disclosed |
| EP-1608658-A1 | CONDENSED BICYCL [3.1.0] HEX-4-EN DERIVATIVES USEFUL AS ANTI BACTERIAL AGENTS | Aston University (GB) | 2005-12-28 | — | — | EP | disclosed |
| WO-2004074293-A1 | CONDENSED BICYCLO`3.1.0!HEX-4-EN DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS | ASTON UNIVERSITY (GB) | 2004-09-02 | — | — | WO | disclosed |
| US-3966751-A | Oxazolidines of 4-oxo-tricyclo[5.1.02.5 ]octan-8-endo-carboxaldehyde, neopentyl glycol acetal | THE UPJOHN COMPANY (US) | 1976-06-29 | — | — | US | disclosed |
| US-3946046-A | Resolution of prostaglandin intermediates by means of oxazolidines | THE UPJOHN COMPANY (US) | 1976-03-23 | — | — | US | disclosed |